Andrew S. Boyer is President & VP at Amneal Pharmaceuticals, Inc. (AMRX). They have made 7 open-market trades across 1 company since 2019, most recently 2026-09-01.
CIK 0001239546
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $745K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRX | SELL | 2025-08-20 | 2025-08-22 | $9.38 | $5.2M | -0.3% | +4.4% | +20.2% |
| AMRX | SELL | 2025-08-12 | 2025-08-13 | $9.05 | $605K | -0.3% | +7.4% | +28.4% |
| AMRX | SELL | 2025-03-05 | 2025-03-07 | $8.89 | $1.1M | +0.3% | -17.1% | -17.6% |
| AMRX | SELL | 2024-08-14 | 2024-08-16 | $7.84 | $983K | +8.4% | +10.6% | +13.4% |
| AMRX | SELL | 2023-08-11 | 2023-08-15 | $4.13 | $242K | +0.0% | +3.8% | +9.5% |
| AMRX | BUY | 2019-08-07 | 2019-08-07 | $2.89 | $385K | -6.8% | -4.2% | +12.1% |
| AMRX | BUY | 2019-05-13 | 2019-05-13 | $9.46 | $359K | -10.4% | -20.5% | -69.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.